Shanghai Sunway Pharmaceutical Technology Co., Ltd. is located in the National Science and Technology Park of the University of Shanghai for Science and Technology and in the Shanghai Qishi Science and Technology Park. Over more than ten years of development, the company has grown into an integrated innovation-driven pharmaceutical service platform that combines R&D, production, sales and service. It has well-established R&D, pilot-scale and production bases in Shanghai, Weifang, Kunming, Zhengzhou and Yantai, and has entered into strategic cooperation with more than 10 well-known universities and laboratories in China. The company has always been committed to providing high-quality products and professional services to customers in the chemical and pharmaceutical R&D fields at home and abroad.
Through unremitting efforts, the company's strength has grown steadily, and outstanding R&D talents continue to gather at Sunway, including more than 10 Ph.D. holders. They have contributed to the R&D of several important national projects, and many of them have been included in the national reserve pool of outstanding scientific research talents.
The company is committed to becoming an integrated comprehensive service platform for the innovative drug industry. Based on the global market, supported by strong scientific research capabilities, closely aligned with industry characteristics and integrating cutting-edge R&D technologies, it responds to customers quickly and efficiently with four core services: custom synthesis and production, new drug R&D, high-end pharmaceutical R&D chemical reagents, and public testing services. Core technical staff lead their teams directly through the R&D process and are proficient in a series of key synthetic technologies, including high-pressure catalysis, ultra-low-temperature reactions, ultra-high-temperature reactions, fluorination, chiral asymmetric synthesis, enzyme catalysis and continuous flow reactions, providing customers with efficient, high-quality services. In addition, the company has built a library of structurally novel building blocks and template molecules covering more than 40 categories. By combining these building blocks and template molecules, large numbers of virtual compounds can be rationally designed, enabling efficient discovery of compound structure-activity relationships, identification of clinical candidates, shorter compound screening cycles and faster drug development.
As your trusted partner in new drug R&D, we are dedicated to helping you accelerate innovative drug development. Every member of our R&D team keeps a firm footing in the present, upholds "customer first" as the primary service principle, aligns personal plans with the company's ultimate goals, overcomes difficulties on the road of innovative drugs and dedicates our strength to the cause of medicine.
We uphold the core values of "Dream, Dedication, Mutual Benefit, Sincerity and Health" and take helping you successfully develop innovative drugs as our mission. We analyze your real needs in depth and provide you with sound and proactive solutions, helping you achieve outstanding results in the wave of innovative drug development. We are proud of every research achievement and honored to play an important role in our customers' success from exploration to development. We look forward to expanding our partnership and setting more milestones in the years ahead.
